pneumococcal 13-valent conjugate vaccine (prevnar 13) Report issue

Vaccine Approved FDA
AACT MeSH

Active Ingredient History

NOW
  • Now
Pneumococcal conjugate vaccine is a pneumococcal vaccine and a conjugate vaccine used to protect infants, young children, and adults against disease caused by the bacterium Streptococcus pneumoniae (pneumococcus). It contains purified capsular polysaccharide of pneumococcal serotypes conjugated to a carrier protein to improve antibody response compared to the pneumococcal polysaccharide vaccine. The World Health Organization (WHO) recommends the use of the conjugate vaccine in routine immunizations given to children.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

13-valent pneumococcal vaccine | bk-um peptide | corynebacterium diphtheriae crm197 protein | crm197 | crm 197 | crm-197 | crm197 (non-toxic variant of diphtheria toxin) | crm(197) of diphtheria toxin | cross reacting material 197 | cross reacting material (crm(197)) of diphtheria toxin | diptheria crm197 protein | diptheria toxin mutant crm19 | nbp606 | pcv13 | pcv-13 | pcv13a | pcv13a vaccine | pcv-13 vaccine | pcv13 vaccine | pneumo-bacterin | pneumococcal 13-valent conjugate vaccine | pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) | pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) | pneumococcal polysaccharide serotype 1 /pneumococcal polysaccharide serotype 1, 4, 5, 6b, 7f, 9v, 14, 18c, 19f, 23f /pneumococcal polysaccharide serotype 14 /pneumococcal polysaccharide serotype 18c /pneumococcal polysaccharide serotype 19f / pneumococcal polysaccharide serotype 23f /pneumococcal polysaccharide serotype 4 /pneumococcal polysaccharide serotype 5 /pneumococcal polysaccharide serotype 6b /pneumococcal polysaccharide serotype 7f /pneumococcal polysaccharide serotype 9v | pneumococcal polysaccharide serotype 1 /pneumococcal polysaccharide serotype 14 /pneumococcal polysaccharide serotype 18c /pneumococcal polysaccharide serotype 19a / pneumococcal polysaccharide serotype 19f /pneumococcal polysaccharide serotype 23f /pneumococcal polysaccharide serotype 3 /pneumococcal polysaccharide serotype 4 / pneumococcal polysaccharide serotype 5 / pneumococcal polysaccharide serotype 6a / pneumococcal polysaccharide serotype 6b /pneumococcal polysaccharide serotype 7f /pneumococcal polysaccharide serotype 9v protein | pneumococcal polysaccharide serotype 4 /pneumococcal polysaccharide serotype 6b /pneumococcal polysaccharide serotype 9v /pneumococcal polysaccharide serotype 14 / pneumococcal oligosaccharide serotype 18c /pneumococcal polysaccharide serotype 19f /pneumococcal polysaccharide serotype 23f | pneumococcal vaccine | prevenar | prevenar13 | prevenar 13 | prevnar | prevnar13 | prevnar 13 | primeboost conjugated anti- pneumococcal vaccine | vi-crm197

Organizations (149)

Research & Development (149)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (130)

Approved Indications (1)


 

Pneumococcal Vaccines (approved 2010)

Experimental Indications - Clinical Trial Phases 1-4 (130)


 

Aging (Early Phase 1)

Anemia, Sickle Cell (Phase 2)

Apnea (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Asthma (Phase 4)

Ataxia Telangiectasia (Phase 3)

Axial Spondyloarthritis (Phase 4)

Bacterial Infections (Phase 3)

BCG Vaccine (Phase 4)

beta-Thalassemia (Phase 4)

Bone Marrow Transplantation (Phase 4)

Breast Neoplasms (Phase 1)

Carcinoma, Hepatocellular (Early Phase 1)

Chickenpox (Phase 3)

Cholangiocarcinoma (Early Phase 1)

Colorectal Neoplasms (Phase 1)

Common Variable Immunodeficiency (Phase 2)

Communicable Diseases (Phase 2)

Coronavirus (Phase 2)

Coronavirus Infections (Phase 4)

Cough (Phase 4)

COVID-19 (Phase 4)

Crohn Disease (Phase 4)

Dengue (Phase 3)

Dengue Virus (Phase 2)

Diphtheria (Phase 4)

Diphtheria-Tetanus-acellular Pertussis Vaccines (Phase 4)

Diphtheria Toxoid (Phase 3)

Drug Therapy, Combination (Phase 4)

Encephalitis (Phase 3)

Esophageal and Gastric Varices (Phase 2)

Fallopian Tube Neoplasms (Phase 1/Phase 2)

Febrile Neutropenia (Phase 4)

Fever (Phase 4)

Haemophilus Infections (Phase 3)

Haemophilus influenzae (Phase 4)

Haemophilus influenzae type b (Phase 3)

Hamartoma (Phase 1/Phase 2)

Healthy Volunteers (Phase 4)

Hematopoietic Stem Cell Transplantation (Phase 3)

Hepatitis A (Phase 4)

Hepatitis A virus (Phase 4)

Hepatitis B (Phase 3)

Herpes Zoster (Phase 3)

HIV (Phase 4)

HIV Infections (Phase 4)

Hypoxia (Phase 3)

IgG Deficiency (Phase 2)

Immune System Diseases (Phase 4)

Immune Tolerance (Phase 2)

Immunity (Phase 4)

Immunization (Phase 4)

Infant (Phase 4)

Infant, Premature, Diseases (Phase 4)

Inflammatory Bowel Diseases (Phase 2)

Influenza, Human (Phase 4)

Intestinal Neoplasms (Phase 1/Phase 2)

Kidney Failure, Chronic (Phase 4)

Kidney Transplantation (Phase 4)

Leukemia (Phase 2)

Leukemia, B-Cell (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Liver Transplantation (Phase 4)

Lupus Erythematosus, Systemic (Phase 4)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 1/Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, Large-Cell, Immunoblastic (Phase 2)

Lymphoma, Mantle-Cell (Phase 1/Phase 2)

Lymphoma, Non-Hodgkin (Phase 1/Phase 2)

Lymphoma, Primary Cutaneous Anaplastic Large Cell (Phase 2)

Malaria (Phase 2)

Measles (Phase 3)

Measles-Mumps-Rubella Vaccine (Phase 3)

Meningitis (Phase 4)

Meningitis, Meningococcal (Phase 4)

Meningococcal Infections (Phase 4)

Meningococcal Vaccines (Phase 3)

Multiple Myeloma (Phase 4)

Multiple Sclerosis (Phase 2)

Mumps (Phase 3)

Mumps Vaccine (Phase 2)

Neisseria meningitidis (Phase 3)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 4)

Otitis Media (Phase 4)

Otitis Media with Effusion (Phase 4)

Ovarian Neoplasms (Phase 1/Phase 2)

Pain (Phase 4)

Pertussis Vaccine (Phase 4)

Pneumococcal Infections (Phase 4)

Pneumococcal Vaccines (Phase 4)

Pneumonia (Phase 4)

Pneumonia, Pneumococcal (Phase 4)

Pneumonia, Staphylococcal (Phase 4)

Poliomyelitis (Phase 4)

Poliovirus Vaccines (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 4)

Premature Birth (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Respiratory Tract Infections (Phase 4)

Rotavirus Infections (Phase 3)

Rotavirus Vaccines (Phase 3)

Rubella (Phase 3)

Rubella Vaccine (Phase 2)

SARS-CoV-2 (Phase 2)

Seizures, Febrile (Phase 4)

Sepsis (Phase 4)

Severe Acute Respiratory Syndrome (Phase 2)

Severe Dengue (Phase 3)

Sjogren's Syndrome (Phase 4)

Spleen (Phase 4)

Splenectomy (Phase 2)

Spondylarthropathies (Phase 4)

Streptococcal Infections (Phase 3)

Streptococcus pneumoniae (Phase 4)

Systemic Vasculitis (Phase 4)

Tetanus (Phase 4)

Thalassemia (Phase 4)

Transplants (Phase 4)

Tuberculosis (Phase 2)

Typhoid Fever (Phase 2)

Urinary Bladder Neoplasms (Phase 1)

Vaccination (Phase 4)

Vaccines (Phase 4)

Virus Diseases (Phase 3)

Whooping Cough (Phase 4)

Yellow Fever (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 300
  • # of Trial Organizations: 149

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue